Creative Biolabs Releases High-quality Bacterial Vaccines Development Services

October 26 09:58 2019

New York, US, October 26, 2019 As Creative Biolabs, a leading custom service provider in the field of vaccine development, releases bacterial vaccine development services forbacterial diseases.

 

Bacterial infectious diseases are the most common diseases that seriously endanger human health. Traditionally, the antibacterial drugs are the main force to treat bacterial diseases but drug abuse also brings the rapid increase of drug-resistant bacteria, leading to less effective control of infections. Therefore, the bacterial vaccines that can improve the resistance of susceptible population to pathogens and reduce the incidence of pathogen infection have become a hot topic in vaccine development field.

 

Supported by the continuous progress of immunology, molecular biology and other sciences, Creative Biolabs is able to stand on the shoulders of giants to provide global clients with various bacterial vaccines development services, which can be customized according to the specific requirements of clients.

 

Killed Bacterial Vaccines: Against cholera, plague, typhus, and Q fever contain whole killed bacteria; only used to protect those likely to be exposed.

Live, Attenuated Bacterial Vaccines: Widely used in the prevention of endemic disease and typhoid fever.

Capsular Polysaccharide Vaccines: Directed against Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidis, and Salmonella typhi.

– Toxoid Vaccines: Against diphtheria and tetanus.

– Purified Protein Vaccines: Commonly used against acellular pertussis and anthrax.

 

Owing to multiple advantages, such as the ability to regulate the amount and in vivo localization of antigen expression, bacteria-based antigen delivery vectors play an increasingly significant role in vaccine development. Creative Biolabs offers a variety of heterologous antigen delivery strategies for bacterial vector vaccine design, such as bacterial surface display systems, bacterial secretion systems, and balanced lethal vector systems to achieve efficient delivery of antigen.

 

Equipped with the advanced technology platform and a professional team. Creative Biolabs can provide a series of bacterial vectors services, including but not limited to:

 

Mycobacterium bovis BCG / actococcus lactis / Salmonella / Bacillus subtilis / Pseudomonas aeruginosa / Shigella / Vibrio Cholerae / Vibrio anguillarum / Corynebacterium pseudotuberculosis / Bordetella pertussis / Streptococcus / Listeria Monocytogenes / Yersinia enterocolitica / Mycobacterium smegmatis / Lactobacillus

 

“We have worked on this vaccine development career for more than ten years. We thoroughly understand the challenges and possibilities during the vaccine development process. A successful project not only requires the reliable tech support but also needs a dynamic collaboration between clients and the company. We can guarantee our clients a trustworthy service within a fast turnaround time,” explained by the manager in Creative Biolabs.

 

More information on vaccine-related products and services can be found at https://www.creative-biolabs.com/vaccine.

 

About the company

Creative Biolabs, headquartered in New York, is a leading custom service provider in the field of vaccine development, preclinical assessment and GMP manufacturing. The technical and regulatory experts can provide vaccine developers with a full range of products and vaccine related services. Traditional and the most updated genetic engineering technologies are combined to efficiently produce highly immunogenic and safe vaccines to address emergency unmet medical needs. The service portfolio includes a full range of vaccine design for client’s specific requirements that covers vaccine target validation, vaccines targeting bacterial, viral, fungal, parasites, cancer markers and more. Formulation optimization services are also available for maximum potency, including improving delivery systems, a great variety of adjuvant products and services like PRR Ligands scanning and adjuvants synthesis.

Media Contact
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Phone: 1-631-619-7922
Address:45-1 Ramsey Road
City: Shirley
State: New York
Country: United States
Website: https://www.creative-biolabs.com/vaccine

  Categories: